Please select the option that best describes you:
Topics:
Hematologic Malignancies • Rheumatology • General Rheumatology • Inflammatory eye disorders • TNF inhibitor • Uveitis and Ocular Immunology
Do you continue TNF inhibitors in patients with a new diagnosis of CLL?
Patient with long standing history of HLAB27 associated uveitis on adalimumab and new diagnosis of CLL.
Answer from: at Academic Institution
If the patient does not require any treatments for CLL that are potentially immunosuppressive, I would continue TNF-inhibitor therapy in this setting. It is always helpful to discuss the case with the patient's hematologist/oncologist to make sure everyone is comfortable with the plan.
Sign in or Register to read more